Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
作者： Shoichiro Tanaka , Minoru Okubo , Kaoru Nagasawa , Soichi Takizawa , Masashi Ichijo
DOI: 10.1007/S13340-015-0211-5
关键词:
摘要: Aims Whether the titer of glutamic acid decarboxylase antibodies (GADAs), especially a low titer, is marker progression beta cell dysfunction in patients with slowly progressive insulin-dependent (type 1) diabetes (SPIDDM) unclear.
springer.com
sci-hub.se 参考文章(25)
Masato Masuda, Michael Powell, Shu Chen, Carolyn Beer, Piotr Fichna, Bernard Rees Smith, Jadwiga Furmaniak, Autoantibodies to IA-2 in insulin-dependent diabetes mellitus: Measurements with a new immunoprecipitation assay Clinica Chimica Acta. ,vol. 291, pp. 53- 66 ,(2000) , 10.1016/S0009-8981(99)00199-0
日本糖尿病学会, Food exchange lists : dietary guidance for persons with diabetes Bunkodo. ,(2003)
Shoichiro Tanaka, , Masayuki Ohmori, Takuya Awata, Akira Shimada, Satoshi Murao, Taro Maruyama, Kyuzi Kamoi, Eiji Kawasaki, Koji Nakanishi, Masao Nagata, Sumie Fujii, Hiroshi Ikegami, Akihisa Imagawa, Yasuko Uchigata, Minoru Okubo, Haruhiko Osawa, Hiroshi Kajio, Akio Kawaguchi, Yumiko Kawabata, Jo Satoh, Ikki Shimizu, Kazuma Takahashi, Hideichi Makino, Hiromi Iwahashi, Junnosuke Miura, Kazuki Yasuda, Toshiaki Hanafusa, Tetsuro Kobayashi, Erratum to: Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): report by the Committee on Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus of the Japan Diabetes Society Diabetology international. ,vol. 6, pp. 1- 7 ,(2015) , 10.1007/S13340-015-0210-6
T. Kobayashi, K. Tamemoto, K. Nakanishi, N. Kato, M. Okubo, H. Kajio, T. Sugimoto, T. Murase, K. Kosaka, Immunogenetic and Clinical Characterization of Slowly Progressive IDDM Diabetes Care. ,vol. 16, pp. 780- 788 ,(1993) , 10.2337/DIACARE.16.5.780
Tetsuro Kobayashi, Yoriko Nishida, Shoichiro Tanaka, Kaoru Aida, Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes-metabolism Research and Reviews. ,vol. 27, pp. 965- 970 ,(2011) , 10.1002/DMRR.1237
M. Desai, C. A. Cull, V. A. Horton, M. R. Christie, E. Bonifacio, V. Lampasona, P. J. Bingley, J. C. Levy, I. R. Mackay, P. Zimmet, R. R. Holman, A. Clark, GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77 Diabetologia. ,vol. 50, pp. 2052- 2060 ,(2007) , 10.1007/S00125-007-0745-6
T. Lohmann, K. Kellner, H.-J. Verlohren, J. Krug, J. Steindorf, W. A. Scherbaum, J. Seissler, Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia. ,vol. 44, pp. 1005- 1010 ,(2001) , 10.1007/S001250100602
Tetsuro Kobayashi, Shoichiro Tanaka, Minoru Okubo, Koji Nakanishi, Toshio Murase, Åke Lernmark, Unique Epitopes of Glutamic Acid Decarboxylase Autoantibodies in Slowly Progressive Type 1 Diabetes The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 4768- 4775 ,(2003) , 10.1210/JC.2002-021529
Tetsuro Kobayashi, Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM — the clinical characteristics and pathogenesis of the syndrome Diabetes Research and Clinical Practice. ,vol. 24, ,(1994) , 10.1016/0168-8227(94)90234-8
S. Yasunaga, A. Kimura, K. Hamaguchi, K. S. Rønningen, T. Sasazuki, Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM) Tissue Antigens. ,vol. 47, pp. 37- 48 ,(1996) , 10.1111/J.1399-0039.1996.TB02512.X